Mega Genomics Limited (HKG:6667)

Hong Kong · Delayed Price · Currency is HKD

6.99

+0.03 (0.43%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Consumer Genetic Testing Services	159.59M	108.38M	80.56M	135.47M	161.71M
Consumer Genetic Testing Services Growth	47.25%	34.54%	-40.53%	-16.23%	51.74%
Cancer Screening Services	4.63M	42.92M	65.17M	100.59M	41.51M
Cancer Screening Services Growth	-89.21%	-34.14%	-35.21%	142.31%	504.06%
Other Services	-	-	-	1.13M	-
Total	164.23M	151.30M	145.73M	237.19M	203.22M
Total Growth	8.54%	3.82%	-38.56%	16.71%	64.28%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Mainland China	164.23M	151.30M	145.73M	237.19M	203.22M
Mainland China Growth	8.54%	3.82%	-38.56%	16.71%	64.28%
Total	164.23M	151.30M	145.73M	237.19M	203.22M
Total Growth	8.54%	3.82%	-38.56%	16.71%	64.28%

Source: S&P Global Market Intelligence.